Submit Press Release GroupWeb News Network Africa Alabama Alaska Arizona Arkansas Asia California China Colorada Connecticut Washington DC Delaware Florida France Georgia Germany Ghana Hawaii Idaho Illinois India Indiana Iowa Italy Japan Kansas Kentucky Korea Lousiana Main MaryLand Massachusetts Michigan Minnesota Mississippi Misouri Motana Nebraska Nevad New Hampshire New Jersey New Mexico New York Nigeria North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island Rhode Island Russia South Africa South Carolina South Dakota Spain Tennessee Texas UK Utah Vermont Virginia Washington Weather West Virginia Wisconsin

Home | Search Global IT News: IT News & Press Release Distribution: Plasma Therapy Market worth 297.6 Million USD by 2021   (IT-NEWSWIRE.COM, January 31, 2017 ) "Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User, Region - Global Forecast to 2021", http://www.marketsandmarkets.com/Market-Reports/cholesterol-testing-services-market-180941049.html The report provides a detailed overview of drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the plasma therapy market, along with estimates and forecast of the revenue and market share analysis. Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=180941049 The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% from 2016 to 2021. Factors driving the growth of the plasma therapy market include rising incidences of trauma and increasing healthcare expenditure worldwide. The global plasma therapy market is segmented on the basis of type, source, application, end user, and region. Among all types, the pure PRP segment is estimated to account for the largest share of the global plasma therapy market in 2016. This segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of the pure PRP segment can be attributed to its high success rate and its antimicrobial effects. Get Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=180941049 On the basis of source, the plasma therapy market is segmented into autologous and allogenic. The autologous segment is estimated to account for the largest share of the global plasma therapy market in 2016, owing to its safety and effective results. Prevalence of orthopedic disorders such as arthritis and tendinitis has propelled the demand for advanced treatment options. This has further contributed to the growth of the plasma therapy market. On the basis of application, the plasma therapy market is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further categorized into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is classified into androgenic alopecia and plastic surgery. Among all applications, the dermatology segment is expected to grow at a high CAGR from 2016 to 2021, owing to increase in the adoption of cosmetic procedures and prevalence of dermatological disorders such as androgenic alopecia. Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=180941049 With respect to end user, the plasma therapy market is segmented into hospitals & clinics and research institutes. The hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy market in 2016. Rise in healthcare spending has resulted in the increasing use of platelet-rich plasma therapy (PRP) in hospitals & clinics. Based on region, the global plasma therapy market is segmented into North America, Europe, Asia-Pacific, and rest of the world (RoW). North America is estimated to account for the largest share of the global plasma therapy market in 2016. This large share is mainly attributed to the increase in aging population and initiatives undertaken by the government to support developments in the field of plasma therapy. Key players in the global plasma therapy market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB S.A. (France), Bio Products Laboratory Ltd. (BPL) (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland). Contact: Mr. Rohan MarketsandMarkets 701 Pike Street Suite 2175, Seattle, WA 98101, United States 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Mr. Rohan 1-888-600-6441 sales@marketsandmarkets.com Source: EmailWire.Com Source: EmailWire.com

Information Technology Resources Application Software Bioinformatics Computers Computer Games Enterprise Software Graphics/Printing/CAD Hardware/Peripheral industrial Computers Information Internet Multimedia Networking Public Sector Robotics Semiconductor Software Telecommunications Webmaster Information Technology (IT) Advertisement Information Technology Sponsors Information Technology Publications We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Information Technology resource center today to browse our selection of 600+ complimentary Information Technology magazines, white papers, webinars, podcasts, and more. Get popular titles including: The Integration Journey—a Field Guide to Enterprise Integration for SOA Government Technology\'s Public CIO Protecting Content During Business Disruption: Are You Covered? No credit cards, coupons, or promo codes required. Try it today!